Lu Xinlin, Shan Guogen
Department of Biostatistics, University of Florida, Gainesville, FL, USA.
Clin Trials. 2025 Jan 25:17407745241309056. doi: 10.1177/17407745241309056.
The sequential parallel comparison design has emerged as a valuable tool in clinical trials with high placebo response rates. To further enhance its efficiency and effectiveness, adaptive strategies, such as sample size adjustment and allocation ratio modification can be employed.
We compared the performance of Jennison and Turnbull's method and the Promising Zone approach for sample size adjustment in a two-phase sequential parallel comparison design study. We also evaluated the impact of allocation ratio adjustments using Neyman and Optimal allocation strategies. Various scenarios were simulated to assess the effects of different design parameters, including weight in the test statistic, initial randomization ratio, and interim analysis timing.
The Promising Zone approach demonstrated superior or comparable power to Jennison and Turnbull's method at equivalent expected sample sizes while maintaining the intuitive property that more promising interim results lead to smaller required follow-up sample sizes. However, the Promising Zone approach may require a larger maximum possible sample size in some cases. The addition of allocation ratio adjustments offered minimal improvements overall, but showed potential benefits when the variance in the treatment group was larger than that in the placebo group. We also applied our findings to a real-world example from the AVP-923 trial in patients with Alzheimer's disease-related agitation, demonstrating the practical implications of adaptive sequential parallel comparison designs in clinical research.
Adaptive strategies can significantly enhance the efficiency of sequential parallel comparison designs. The choice between sample size adjustment methods should consider trade-offs between power, expected sample size, and maximum adjusted sample size. Although allocation ratio adjustments showed limited overall impact, they may be beneficial in specific scenarios. Future research should explore the application of these adaptive strategies to binary and survival outcomes in sequential parallel comparison designs.
序贯平行比较设计已成为安慰剂反应率高的临床试验中的一种有价值的工具。为了进一步提高其效率和有效性,可以采用样本量调整和分配比修改等自适应策略。
在一项两阶段序贯平行比较设计研究中,我们比较了詹尼森和特恩布尔方法以及“有前景区域”方法在样本量调整方面的性能。我们还评估了使用奈曼和最优分配策略进行分配比调整的影响。模拟了各种场景,以评估不同设计参数的影响,包括检验统计量中的权重、初始随机化比例和期中分析时间。
在等效预期样本量的情况下,“有前景区域”方法显示出与詹尼森和特恩布尔方法相当或更高的检验效能,同时保持了更有前景的期中结果会导致所需的后续样本量更小这一直观特性。然而,在某些情况下,“有前景区域”方法可能需要更大的最大可能样本量。分配比调整总体上带来的改善很小,但当治疗组的方差大于安慰剂组时显示出潜在益处。我们还将我们的研究结果应用于阿尔茨海默病相关激越患者的AVP - 923试验的一个实际例子,证明了自适应序贯平行比较设计在临床研究中的实际意义。
自适应策略可以显著提高序贯平行比较设计的效率。样本量调整方法之间的选择应考虑检验效能、预期样本量和最大调整样本量之间的权衡。尽管分配比调整的总体影响有限,但在特定场景中可能有益。未来的研究应探索这些自适应策略在序贯平行比较设计中的二元和生存结局中的应用。